Related Experiment Videos
Cerebral venous thrombosis
1Service de Neurologie, Hôpital Saint-Antoine, Paris, France.
Insights
Cerebral venous thrombosis (CVT) is increasingly recognized with neuroimaging, presenting diverse symptoms. Early diagnosis and treatment, particularly with heparin, significantly improve patient outcomes, with a low fatality rate and high recovery potential.
Area of Science:
- Neurology
- Radiology
- Vascular Medicine
Background:
- Cerebral venous thrombosis (CVT) is increasingly diagnosed due to advanced neuroimaging.
- CVT diagnosis is challenging due to varied clinical presentations and onset patterns.
- Multiple predisposing factors, often non-infectious, necessitate thorough etiological investigation.
Purpose of the Study:
- To highlight the improved recognition and prognosis of CVT.
- To emphasize the diagnostic challenges and necessary work-up.
- To underscore the efficacy of heparin in CVT management.
Main Methods:
- Review of neuroimaging findings in CVT diagnosis.
- Analysis of clinical presentations and etiologies of CVT.
- Evaluation of treatment outcomes, focusing on heparin efficacy.
Main Results:
- Neuroimaging facilitates earlier CVT detection, revealing it to be more common than previously thought.
- CVT exhibits a broad spectrum of clinical symptoms and variable onset.
- Non-infectious CVT has a favorable prognosis, with <10% fatality and >70% complete recovery.
Conclusions:
- CVT is more common and treatable than historically believed.
- Prompt diagnosis and etiological work-up are crucial for effective CVT management.
- Heparin therapy is well-established and effective for CVT, improving patient outcomes.
Abstract:
Neuroimagining facilities allow early recognition of cerebral venous thrombosis (CVT), which now appears far more common than previously assumed. The diagnosis remains difficult because of a wide spectrum of clinical presentation and a highly variable mode of onset. Numerous conditions (presently mostly noninfectious) can cause or predispose to CVT, which therefore requires an extensive etiologic work-up. The functional and vital prognosis is much better than classically thought with, in noninfectious CVT, a fatality rate of less than 10% and a complete recovery in over 70%. Although spontaneous recovery is possible, the efficacy of heparin is now well established.